ArticleBioMed research international2026
Bacteria Associated With Urinary Tract Infections, Antimicrobial Resistance Profiles, and Associated Factors Among Diabetes Mellitus Patients at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPatients with diabetes mellitus are at increased risk of urinary tract infections (UTIs) due to impaired immune function and metabolic changes, which may lead to serious complications and increased healthcare burdens. In the catchment area of Debre Tabor, northwest Ethiopia, data on UTI-causing bacteria and their antimicrobial resistance profiles among diabetic patients remain limited. Given the rising threat of antimicrobial resistance, continuous local surveillance is essential for effective management and antibiotic stewardship. This study is aimed at determining the bacterial etiologies associated with UTIs, their resistance profiles, and associated factors among diabetic patients at Debre Tabor Comprehensive Specialized Hospital.
methodsA cross-sectional study was conducted from May 15, 2022 to July 13, 2022 among 246 diabetic patients who were recruited using convenience sampling technique. Sociodemographic and clinical data were collected using a structured questionnaire. Midstream urine samples were collected for bacterial isolation, identification, and antimicrobial susceptibility testing using standard bacteriological methods. Data were entered and analyzed using SPSS Version 25 software. Descriptive statistics were used to summarize the data, and binary logistic regression was performed to identify factors associated with UTIs. A p value <0.05 with a 95% confidence interval was considered statistically significant.
resultsIn this study, the overall prevalence of significant bacteriuria was 35/246 (14.2%). Of the 35 isolates, the majority 29 (82.9%) were Gram-negative bacteria. The predominant isolate was Escherichia coli at 18 (51.4%). Gram-negative isolates were resistant to amoxicillin, trimethoprim/sulfamethoxazole, and cefotaxime at rates of 57.1%, 39.3%, and 35.7%. The proportion of antibiotic resistance among Gram-positive bacteria ranged from 33.3% to 100%. Enterococcus species showed resistance to all tested antimicrobials. The overall multidrug resistance rate was 25.7%. Having symptoms of UTI (AOR: 9.57, 95% CI: 2.27-40.35) and being female (AOR: 2.63, 95% CI: 1.01-6.84) were significantly associated with significant bacteriuria.
conclusionA considerable prevalence of significant bacteriuria was observed. Moreover, bacterial isolates demonstrated moderately high resistance to commonly used antimicrobials. Regular monitoring of antimicrobial resistance patterns and strengthening infection prevention strategies among diabetic patients in the study area are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.